The results herein reported also pave the way for further studies designed to assess whether A2A receptor changes occur in ALS patients and if so, whether they are restricted to those with SOD1 gene mutations or are present in all ALS forms. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.